Abstract
A paucity of research exists examining the potential impact of tobacco use on cancer treatment outcomes, especially among patients treated with hematopoietic SCT (HSCT). A retrospective cohort study design was used to examine the impact of smoking on duration of hospitalization and overall survival among 148 consecutive patients undergoing HSCT for treatment of acute leukemia from 1999 to 2005. Of the 148 patients, 15% reported current smoking, 30% former smoking, and 55% never used tobacco. Patients were followed for a median 3.5 years (interquartile range=2.1–5.5). Compared to no history of smoking, current smoking was associated with worse pre-HSCT pulmonary function tests (P<0.02 in each case), more days hospitalization (46.2 days versus 25.7 days, P=0.025), and poorer overall survival (hazard ratio (HR)=1.88; 95% CI 1.09–3.25). Results were similar after multivariate adjustment, although the association with overall survival attenuated slightly (HR=1.75; 95% CI 1.00–3.06). Current smoking appears to adversely affect the number of days hospitalized post HSCT and overall survival. Translational research focused on interventions to promote tobacco cessation may lead to improved HSCT outcomes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Anonymous. The 2004 United States Surgeon General's Report: The Health Consequences of Smoking. N S W Public Health Bull 2004; 15: 107.
Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP . Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer 2006; 106: 17–27.
Bishop MM, Rodrigue JR, Wingard JR . Mismanaging the gift of life: noncompliance in the context of adult stem cell transplantation. Bone Marrow Transplant 2002; 29: 875–880.
Bellizzi KM, Rowland JH, Jeffery DD, McNeel T . Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol 2005; 23: 8884–8893.
Coups EJ, Ostroff JS . A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med 2005; 40: 702–711.
Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ . Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. US Department of Health and Human Services, Public Health Service: Rockville, MD, 2008.
Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ . Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 223–229.
Thompson AM, Couch M, Zahurak ML, Johnson C, Vogelsang GB . Risk factors for post-stem cell transplant sinusitis. Bone Marrow Transplant 2002; 29: 257–261.
Chang G, Orav EJ, McNamara T, Tong MY, Antin JH . Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome. Cancer 2004; 101: 782–789.
Sharma S, Nadrous HF, Peters SG, Tefferi A, Litzow MR, Aubry MC et al. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest 2005; 128: 1385–1392.
Savani BN, Montero A, Wu C, Nlonda N, Read E, Dunbar C et al. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 223–230.
Marks DI, Ballen K, Logan BR, Wang Z, Sobocinski KA, Bacigalupo A et al. The effect of smoking on allogeneic transplant outcomes. Biol Blood Marrow Transplant 2009; 15: 1277–1287.
Miceli MH, Dong L, Grazziutti ML, Fassas A, Thertulien R, Van Rhee F et al. Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients. Bone Marrow Transplant 2006; 37: 857–864.
Wilczynski SW, Erasmus JJ, Petros WP, Vredenburgh JJ, Folz RJ . Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am J Respir Crit Care Med 1998; 157: 565–573.
Hoodin F, Kalbfleisch KR, Thornton J, Ratanatharathorn V . Psychosocial influences on 305 adults' survival after bone marrow transplantation; depression, smoking, and behavioral self-regulation. J Psychosom Res 2004; 57: 145–154.
FACT, Foundation for the Accreditation of Cellular Therapy Available at http://www.factwebsite.org. Accessed 10 February 2008.
Gritz ER, Carr CR, Rapkin D, Abemayor E, Chang LJ, Wong WK et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1993; 2: 261–270.
Sandhu S, Humphris G, Whitley S, Cardozo A, Sandhu A . Smoking habits in patient's who have been treated for an oral cancer: validation of self-report using saliva cotinine. Oral Oncol 2004; 40: 576–578.
Levit K, Stranges E, Ryan K, Elixhauser A . HCUP Facts and Figures 2006: Statistics on Hospital-based Care in the United States. Agency for Healthcare Research and Quality: Rockville, MD, 2008. Available at http://www.hcup-us.ahrq.gov/reports.jsp Accessed on 30 September 2009..
Zeidel A, Beilin B, Yardeni I, Mayburd E, Smirnov G, Bessler H . Immune response in asymptomatic smokers. Acta Anaesthesiol Scand 2002; 46: 959–964.
US Department of Health and Human Services. Centers for Disease Control and Prevention. The health consequences of smoking: a report of the surgeon general. 2004. Available at http://www.cdc.gov/tobacco/data_statistics/sgr/2004/index.htm. Accessed on 15 March 2009.
Stevens MH, Gardner JW, Parkin JL, Johnson LP . Head and neck cancer survival and life-style change. Arch Otolaryngol 1983; 109: 746–749.
Acknowledgements
We gratefully acknowledge the contributions of Norine Huneke, Lindsay Deling, Cameron Rismas, Carl Greiner, and Andrew Hanson for data collection and analysis support. We also acknowledge the Mayo Clinic Blood and Marrow Transplant Practice Group, who share day-to-day management responsibilities for patients and contribute to the data quality. This study was funded by a small grant from the Mayo Clinic Department of Psychiatry and Psychology and grant KL2 RR024151 from the National Institutes of Health (NIH).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ehlers, S., Gastineau, D., Patten, C. et al. The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia. Bone Marrow Transplant 46, 285–290 (2011). https://doi.org/10.1038/bmt.2010.113
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.113
Keywords
This article is cited by
-
Survival protection of patients undergoing hematopoietic stem cell transplantation: grounded theory
Supportive Care in Cancer (2023)
-
Clinical impact of cigarette smoking on the outcomes of allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study
Bone Marrow Transplantation (2022)
-
Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres
Implementation Science (2021)
-
Smoking cessation care can translate to lower hazard of death in the short-run in cancer patients - a retrospective cohort study to demonstrate the value of smoking cessation services within the treatment phase of cancer
BMC Cancer (2019)
-
Effects of smoking on outcomes of hematopoietic cell transplantation: a systemic review and future directions
Bone Marrow Transplantation (2019)